Health
De novo designed SARS-CoV-2 nanoparticle vaccine – News-Medical.Net
In light of the continuing threat to public health, social functioning, and economic activity posed by the COVID-19 pandemic, scientists are working urgently to bring out a vaccine that is both safe and effective, and capable of mass production. A new paper p…
In light of the continuing threat to public health, social functioning, and economic activity posed by the COVID-19 pandemic, scientists are working urgently to bring out a vaccine that is both safe and effective, and capable of mass production. A new paper published on the preprint server bioRxiv* in August 2020 shows that such a vaccine may be produced by using arrays of one severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) protein on a nanoparticle platform.
The Receptor-Binding D…
-
Business24 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
Noosa News21 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites
-
General8 hours agoPoliticians asked how to Trump-proof Australia’s fragile economy on Q+A
-
Business21 hours ago1 ASX dividend stock down 43% I’d buy right now